Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can m ...

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Highlights of the findings include: Stopping Ozempic three to five days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia. In contrast ...

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

"Concerns arise over GLP-1 use during major surgeries like joint replacements. A study reveals optimal timing for stopping Ozempic to reduce anesthesia risks." ...